Filed with the SEC on · Summarized by InvestorsBot
ResMed Chairman and CEO and Director Michael J. Farrell sold 4,991 shares of common stock on Aug. 7 at $205.69 per share, for approximately $1.03 million. He owned 466,256 shares after the transaction.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeResMed starts $450 million accelerated share repurchase with Citibank
8-K · September 1, 2026
ResMed appoints Carol Burt as lead director as Ron Taylor plans retirement
8-K · August 17, 2026
ResMed Names Carol Burt Lead Director as Ron Taylor Plans Board Retirement
8-K · August 17, 2026
ResMed replaces KPMG with PwC as independent auditor
8-K · August 17, 2026
ResMed filed an 8‑K (Item 9.01) attaching a press release dated Jan 29, 2026 reporting results of…
8-K · January 29, 2026
ResMed ($RMD) board declared a quarterly cash dividend of $0.60/share.
8-K · January 29, 2026